3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
46
Lymphoma, Mantle-Cell
20
Lymphoma, Follicular
13
Waldenstrom Macroglobulinemia
12
Lymphoma, Non-Hodgkin
12
Lymphoma, Large B-Cell, Diffuse
12
Lymphoma
11
Lymphoma, B-Cell
10
Leukemia
9
Recurrence
8
Multiple Myeloma
5
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Lymphoid
4
Leukemia, B-Cell
4
Hodgkin Disease
4
Bronchiolitis Obliterans Syndrome
4
Hematologic Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms, Plasma Cell
2
Neoplasms
2
Lung Neoplasms
2
Leukemia, Prolymphocytic
2
Leukemia, Myeloid, Acute
2
Graft vs Host Disease
2
Chromosome 17 deletion
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Interventions
antineoplaston AS 2-1
3
antineoplaston A10
3
dactolisib
2
Temozolomide
2
Irinotecan
2
Everolimus
2
Bevacizumab
2
surufatinib
1
spartalizumab
1
poly ICLC
1
plerixafor
1
pasireotide
1
fosbretabulin
1
cixutumumab
1
adavosertib
1
Vaccines
1
TH 302
1
Sunitinib
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Radiation
1
PM 00104
1
Lapatinib
1
Immunologic Techniques
1
Immunoglobulin G
1
Genistein
1
Fentanyl
1
Donepezil
1
Disulfides
1
Decitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroectodermal Tumors, Primitive
×
ibrutinib
×
Clear all
No trials found.